GCSF
Sponsors
Hospira UK Ltd, Northwestern University, Massachusetts General Hospital, Tianjin SinoBiotech Ltd., National University Hospital, Singapore
Conditions
Acute Lymphoid Leukemia (ALL)Acute Myeloid Leukemia (AML)Acute-On-Chronic Liver FailureAlcoholic HepatitisCervix CancerChemotherapy-induced NeutropeniaChronic Granulomatous DiseaseDecompensated Cirrhosis
Phase 1
Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
TerminatedNCT00282412
Start: 2002-09-30End: 2016-06-30Updated: 2018-07-30
PCI-24781 in Combination With Doxorubicin to Treat Sarcoma
CompletedNCT01027910
Start: 2009-02-28End: 2015-03-31Updated: 2025-07-24
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
TerminatedNCT04514692
Start: 2021-02-01End: 2023-09-27Updated: 2025-04-23
Phase 2
Meloxicam vs Placebo for Mobilization
CompletedNCT02003625
Start: 2013-10-31End: 2019-04-30Updated: 2020-05-18
Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein
CompletedNCT02465801
Start: 2014-12-16End: 2016-04-26Updated: 2017-07-18
Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients
CompletedNCT03251768
Start: 2017-10-19End: 2019-04-24Updated: 2019-09-13
Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients
NCT03547830
Start: 2019-04-13End: 2023-01-01Target: 17Updated: 2019-09-17
A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
Active, not recruitingNCT04872595
Start: 2021-04-30End: 2026-04-30Updated: 2025-09-04
Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Active, not recruitingNCT05498220
Start: 2023-02-17End: 2026-11-07Updated: 2025-09-02
Mozobil for Autologous Hematopoietic Stem Cell Transplantation
RecruitingNCT07188090
Start: 2025-10-16End: 2028-06-30Target: 100Updated: 2025-11-28
Phase 3
A Phase III randomised, multicentre, double-blind, therapeutic equivalence study of biosimilar G-CSF (PLIVA/Mayne filgrastim) versus Neupogen (filgrastim-Amgen) in subjects receiving doxorubicin and docetaxel as a combination chemotherapy for breast cancer
Active, not recruitingEUCTR2007-000394-36-GB
Start: 2007-09-07Target: 279Updated: 2019-11-25
Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis
NCT03109236
Start: 2017-08-24End: 2023-12-31Target: 66Updated: 2021-01-19
Phase 4
Unknown Phase
To Assess the Efficacy of High-Volume Plasma Exchange and GCSF Versus GCSF Alone in Patients of Acute on Chronic Liver Failure (ACLF).
WithdrawnNCT03162419
Start: 2017-05-01End: 2019-04-25Updated: 2018-12-03
Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.
NCT04066179
Start: 2019-09-07End: 2021-02-27Target: 126Updated: 2019-09-09
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis
Not yet recruitingNCT07131280
Start: 2025-09-30End: 2031-12-31Target: 110Updated: 2025-08-20